Roivant Sciences

ROIV

NASDAQHealth Care

Income Statement

Total Revenue$50.41M

Gross Profit$45.3M

Operating Income$0

EBITDA$0

EBIT$-1.09B

Pre-tax Income$-669.99M

Net Income$-116.62M

Net Cash$990.83M

Cash Equivalent$5.15B

Total Debt$0

Net Debt$-990.83M

Book Value$5.97K

Net Cash Per Share1380000.00

Book Value Per Share7.40

Return on Equity (ROE)-3.67%

Return on Assets (ROA)-3.16%

Return on Invested Capital (ROI)-3.67%

Net Profit Margin-591.96%

Current Ratio33.47

Quick Ratio33.47

Long-Term Debt / Equity0.07